Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2021 Filed Nov 12, 2021 17:27 UTC |
Foster Jon MGroup President
|
Exercise / conversionCommon Stock | 33,375 | $47.97 | $1,600,998.75 |
DisclosureSEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 7 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2021 Filed Nov 12, 2021 17:26 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 3,364 | $249.61 | $839,689.05 |
DisclosureSEC source: 0001209191-21-064276 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.60 to $249.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:03 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 2,760 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-21-063966 · doc4.xml · derivative · entry 5 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280 Underlying: Common Stock · 2,760 shares Expires 2030-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:03 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 5,335 | $0.00 Strike: $139.06 | $0.00 |
DisclosureSEC source: 0001209191-21-063966 · doc4.xml · derivative · entry 4 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,335 Underlying: Common Stock · 5,335 shares Expires 2029-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:03 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Tax withholdingCommon Stock | 5,986 | $247.63 | $1,482,313.18 |
DisclosureSEC source: 0001209191-21-063966 · doc4.xml · nonDerivative · entry 3 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,008 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:03 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 2,760 | $145.24 | $400,862.40 |
DisclosureSEC source: 0001209191-21-063966 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:03 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 5,335 | $139.06 | $741,885.10 |
DisclosureSEC source: 0001209191-21-063966 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:03 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Exercise / conversionStock Appreciation Right · Derivative | 7,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-21-063964 · doc4.xml · derivative · entry 5 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:03 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Exercise / conversionStock Appreciation Right · Derivative | 7,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-21-063964 · doc4.xml · derivative · entry 4 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:03 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Tax withholdingCommon Stock | 6,748 | $247.63 | $1,671,007.24 |
DisclosureSEC source: 0001209191-21-063964 · doc4.xml · nonDerivative · entry 2 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,361.427 F1 · balance_after: Includes 2,049.427 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:03 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Exercise / conversionCommon Stock | 15,000 | $22.95 | $344,250.00 |
DisclosureSEC source: 0001209191-21-063964 · doc4.xml · nonDerivative · entry 1 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,109.427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,049.427 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 19:02 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 5,510 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-21-063720 · doc4.xml · derivative · entry 5 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,510 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 19:02 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 5,130 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-21-063720 · doc4.xml · derivative · entry 4 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,130 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 19:02 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Tax withholdingCommon Stock | 6,163 | $248.27 | $1,530,088.01 |
DisclosureSEC source: 0001209191-21-063720 · doc4.xml · nonDerivative · entry 3 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,857 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 19:02 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Exercise / conversionCommon Stock | 5,510 | $81.96 | $451,599.60 |
DisclosureSEC source: 0001209191-21-063720 · doc4.xml · nonDerivative · entry 2 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 19:02 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Exercise / conversionCommon Stock | 5,130 | $69.58 | $356,945.40 |
DisclosureSEC source: 0001209191-21-063720 · doc4.xml · nonDerivative · entry 1 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 19:02 UTC |
Wyatt Christopher F.SVP & Controller
|
SaleCommon Stock | 2,100 | $252.94 | $531,174.00 |
DisclosureSEC source: 0001209191-21-063722 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,820 Read SEC document |
| November 04, 2021 Filed Nov 4, 2021 18:22 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
SaleCommon Stock | 3,815 | $250.48 | $955,597.99 |
DisclosureSEC source: 0001209191-21-062999 · doc4.xml · nonDerivative · entry 4 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,877 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.141 to $250.84, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:25 UTC |
RUTHERFORD BILL BCFO and EVP
|
SaleCommon Stock | 20,647 | $250.00 | $5,161,750.00 |
DisclosureSEC source: 0001209191-21-063264 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,009 Read SEC document |
| November 04, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 10 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,627.8464 F1 · balance_after: Includes 169.6229 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 18:26 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 7,688 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-21-063265 · doc4.xml · derivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,688 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 18:26 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Tax withholdingCommon Stock | 4,324 | $250.00 | $1,081,000.00 |
DisclosureSEC source: 0001209191-21-063265 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,364 Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 18:26 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionCommon Stock | 7,688 | $69.58 | $534,931.04 |
DisclosureSEC source: 0001209191-21-063265 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 18:25 UTC |
RUTHERFORD BILL BCFO and EVP
|
SaleCommon Stock | 9,353 | $250.00 | $2,338,250.00 |
DisclosureSEC source: 0001209191-21-063264 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,656 Read SEC document |
| November 03, 2021 Filed Feb 1, 2022 19:34 UTC |
RUTHERFORD BILL BCFO and EVP
|
GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006084 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,809 Read SEC document |
| November 02, 2021 Filed Nov 2, 2021 19:34 UTC |
HAZEN SAMUEL NDirector · CEO
|
SaleCommon Stock | 3,159 | $252.44 | $797,465.23 |
DisclosureSEC source: 0001209191-21-062527 · doc4.xml · nonDerivative · entry 5 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,664 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.24 to $252.76, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2021 Filed Nov 2, 2021 19:34 UTC |
HAZEN SAMUEL NDirector · CEO
|
SaleCommon Stock | 38,260 | $251.84 | $9,635,230.06 |
DisclosureSEC source: 0001209191-21-062527 · doc4.xml · nonDerivative · entry 4 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,823 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.24 to $252.23, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2021 Filed Nov 2, 2021 19:34 UTC |
HAZEN SAMUEL NDirector · CEO
|
SaleCommon Stock | 8,581 | $250.96 | $2,153,528.09 |
DisclosureSEC source: 0001209191-21-062527 · doc4.xml · nonDerivative · entry 3 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,083 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.24 to $251.23, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 18:22 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 5,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-21-062999 · doc4.xml · derivative · entry 7 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 18:22 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 700 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-062999 · doc4.xml · derivative · entry 6 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 700 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 18:22 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 2,625 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-062999 · doc4.xml · derivative · entry 5 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,625 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 18:22 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Tax withholdingCommon Stock | 4,510 | $248.44 | $1,120,464.40 |
DisclosureSEC source: 0001209191-21-062999 · doc4.xml · nonDerivative · entry 3 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,692 Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 18:22 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionCommon Stock | 5,000 | $68.96 | $344,800.00 |
DisclosureSEC source: 0001209191-21-062999 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 18:22 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionCommon Stock | 3,325 | $47.97 | $159,500.25 |
DisclosureSEC source: 0001209191-21-062999 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:36 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionStock Appreciation Right · Derivative | 5,260 | $0.00 Strike: $79.80 | $0.00 |
DisclosureSEC source: 0001209191-21-062529 · doc4.xml · derivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,260 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on May 4, 2017. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:36 UTC |
Wyatt Christopher F.SVP & Controller
|
Tax withholdingCommon Stock | 3,087 | $250.46 | $773,170.02 |
DisclosureSEC source: 0001209191-21-062529 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,920 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:36 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionCommon Stock | 5,260 | $79.80 | $419,748.00 |
DisclosureSEC source: 0001209191-21-062529 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:35 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionStock Appreciation Right · Derivative | 36,125 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-062528 · doc4.xml · derivative · entry 8 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,125 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:35 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionStock Appreciation Right · Derivative | 42,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-062528 · doc4.xml · derivative · entry 7 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:35 UTC |
RUTHERFORD BILL BCFO and EVP
|
Tax withholdingCommon Stock | 40,073 | $250.46 | $10,036,683.58 |
DisclosureSEC source: 0001209191-21-062528 · doc4.xml · nonDerivative · entry 3 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,009 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:35 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 78,625 | $47.97 | $3,771,641.25 |
DisclosureSEC source: 0001209191-21-062528 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:34 UTC |
HAZEN SAMUEL NDirector · CEO
|
Exercise / conversionStock Appreciation Right · Derivative | 70,125 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-062527 · doc4.xml · derivative · entry 8 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,125 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:34 UTC |
HAZEN SAMUEL NDirector · CEO
|
Exercise / conversionStock Appreciation Right · Derivative | 82,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-062527 · doc4.xml · derivative · entry 7 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:34 UTC |
HAZEN SAMUEL NDirector · CEO
|
Tax withholdingCommon Stock | 77,790 | $250.46 | $19,483,283.40 |
DisclosureSEC source: 0001209191-21-062527 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,664 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:34 UTC |
HAZEN SAMUEL NDirector · CEO
|
Exercise / conversionCommon Stock | 152,625 | $47.97 | $7,321,421.25 |
DisclosureSEC source: 0001209191-21-062527 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2021 Filed Feb 1, 2022 19:23 UTC |
Hall Charles JGroup President
|
GiftCommon Stock | 4,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006073 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,700 Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 19:18 UTC |
Cuffe Michael S.President-Physician Services
|
GrantStock Appreciation Right · Derivative | 7,350 | $0.00 Strike: $241.81 | $0.00 |
DisclosureSEC source: 0001209191-21-061840 · doc4.xml · derivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,350 Underlying: Common Stock · 7,350 shares Expires 2031-10-25 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on October 25, 2022. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:37 UTC |
Johnston Hugh FDirector
|
GrantCommon Stock | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054775 · doc4.xml · nonDerivative · entry 1 Johnston Hugh F · CIK 0001377489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465 F1 · kind: Represents common stock underlying 455 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2022 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 17:33 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 4,018 | $250.12 | $1,004,996.62 |
DisclosureSEC source: 0001209191-21-050439 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 21:02 UTC |
Hall Charles JGroup President
|
SaleCommon Stock | 3,000 | $253.94 | $761,820.00 |
DisclosureSEC source: 0001209191-21-049817 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,870 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.